Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy.

Area of Science:

• Immunology
• Allergy Research
• Vaccine Development

Background:

• Aluminum hydroxide (alum) is a common adjuvant in allergen-specific immunotherapy, but can cause systemic anaphylactic side-effects.
• Recombinant Phl p 5b, a major timothy grass pollen allergen, is used to study adjuvant efficacy.

Purpose of the Study:

• To evaluate carbohydrate-based particles (CBP) as a potential adjuvant for immunotherapy, comparing its efficacy and safety to alum.
• To investigate the immune response induced by CBP-bound recombinant Phl p 5b (rPhl p 5b) in mice.

Main Methods:

• Mice were immunized with rPhl p 5b bound to either CBP or alum, or with unbound rPhl p 5b.
• Antibody and cytokine responses (Th1/Th2) were analyzed.
• Cross-reactivity of induced antibodies and inhibition of patient IgE binding were assessed.
• Tissue reactions to alum and CBP were examined.

Main Results:

• CBP-bound rPhl p 5b induced stronger antibody and cytokine responses than unbound rPhl p 5b.
• Antibodies from CBP-bound rPhl p 5b showed cross-reactivity with other grass allergens and inhibited patient IgE binding.
• CBP induced a mixed Th1/Th2 immune response, unlike alum which induced a Th2-biased response.
• CBP formed a stable vaccine formulation without causing granulomatous tissue reactions, unlike alum.

Conclusions:

• Carbohydrate-based particles (CBP) represent a potentially advantageous adjuvant for specific immunotherapy of IgE-mediated allergies.
• CBP elicits beneficial immune responses and demonstrates a favorable safety profile compared to alum.